Actionable news
0
All posts from Actionable news
Actionable news in AERI: Aerie Pharmaceuticals, Inc.,

Schedule 13G/A

Filed by: JENNISON ASSOCIATES LLC
Total Shares: 1,885,085
Subject Company: Aerie Pharmaceuticals - View Complete Ownership History Backtest
Filed as of Date: 07/10/2017
Event Date: 06/30/2017
Overall % Ownership: 5.2

Reporting Persons

Name Sole
Voting Power
Shared
Voting Power
Sole
Dispositive Power
Shared
Dispositive Power
Aggregate
Amount Owned
Percent
of class
Identification #522069785 (formerly 132631108) 1,885,075 0 0 1,885,075 1,885,085 5.2%

Raw Filing Contents

0000053417-17-000126.txt : 20170710

0000053417-17-000126.hdr.sgml : 20170710
20170710123251
ACCESSION NUMBER:		0000053417-17-000126
CONFORMED SUBMISSION TYPE:	SC 13G/A
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20170710
DATE AS OF CHANGE:		20170710

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			AERIE PHARMACEUTICALS INC
		CENTRAL INDEX KEY:			0001337553
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				203109565
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SC 13G/A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	005-87680
		FILM NUMBER:		17956982

	BUSINESS ADDRESS:	
		STREET 1:		7020 KIT CREEK ROAD
		STREET 2:		SUITE 270
		CITY:			RESEARCH TRIANGLE PARK
		STATE:			NC
		ZIP:			27709
		BUSINESS PHONE:		919-313-9650

	MAIL ADDRESS:	
		STREET 1:		7020 KIT CREEK ROAD
		STREET 2:		SUITE 270
		CITY:			RESEARCH TRIANGLE PARK
		STATE:			NC
		ZIP:			27709

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			JENNISON ASSOCIATES LLC
		CENTRAL INDEX KEY:			0000053417
		IRS NUMBER:				132631108
		STATE OF INCORPORATION:			NY
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SC 13G/A

	BUSINESS ADDRESS:	
		STREET 1:		466 LEXINGTON AVE
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10017
		BUSINESS PHONE:		2124211000

	MAIL ADDRESS:	
		STREET 1:		466 LEXINGTON AVE
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10017

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	JENNISON ASSOCIATES CAPITAL CORP
		DATE OF NAME CHANGE:	19940511

SC 13G/A 1 aeri617.txt 13G AMENDED MONTHLY FILING - AERI

Securities and Exchange Commission Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No. 4)* June 30, 2017 (Date of event which requires filing of this statement) Check the appropriate box to designate the rule pursuant to which this schedule is filed: (X) Rule 13d-1(b) ( ) Rule 13d-1(c) ( ) Rule 13d-1(d) Name of Issuer: Aerie Pharmaceuticals Inc. Title of Class of Securities: Common Stock CUSIP Number: 00771V108 *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect...


More